These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8281163)

  • 21. Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.
    Hastie ND
    Hum Mol Genet; 1992 Aug; 1(5):293-5. PubMed ID: 1338905
    [No Abstract]   [Full Text] [Related]  

  • 22. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical mutation in both WT1 alleles is not sufficient to cause Wilms' tumor.
    Kikuchi H; Akasaka Y; Kurosawa Y; Yoneyama H; Kato S; Hata J
    FEBS Lett; 1995 Feb; 360(1):26-8. PubMed ID: 7875294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.
    Baird PN; Santos A; Groves N; Jadresic L; Cowell JK
    Hum Mol Genet; 1992 Aug; 1(5):301-5. PubMed ID: 1338906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
    Bardeesy N; Zabel B; Schmitt K; Pelletier J
    Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
    [No Abstract]   [Full Text] [Related]  

  • 27. WT1 mutation as a cause of 46 XY DSD and Wilm's tumour: a case report and literature review.
    Dai YL; Fu JF; Hong F; Xu S; Shen Z
    Acta Paediatr; 2011 Jul; 100(7):e39-42. PubMed ID: 21314844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome.
    Perotti D; Mondini P; Giardini R; Ferrari A; Massimino M; Gambirasio F; Pierotti MA; Fossati-Bellani F; Radice P
    Ann Oncol; 1998 Jun; 9(6):627-31. PubMed ID: 9681076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Drash syndrome revisited: diagnosis and follow-up.
    Friedman AL; Finlay JL
    Am J Med Genet Suppl; 1987; 3():293-6. PubMed ID: 2835969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
    Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
    Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome.
    Vicanek C; Ferretti E; Goodyer C; Torban E; Moffett P; Pelletier J; Goodyer P
    Kidney Int; 1997 Sep; 52(3):614-9. PubMed ID: 9291179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Denys-Drash syndrome.
    Mueller RF
    J Med Genet; 1994 Jun; 31(6):471-7. PubMed ID: 8071974
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome.
    Ghahremani M; Chan CB; Bistritzer T; Aladjem MM; Tieder M; Pelletier J
    Hum Hered; 1996; 46(6):336-8. PubMed ID: 8956030
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel zinc finger mutation in a patient with Denys-Drash syndrome.
    Baird PN; Cowell JK
    Hum Mol Genet; 1993 Dec; 2(12):2193-4. PubMed ID: 8111391
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
    Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
    Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
    Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
    Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.